Table 2.

Distribution of Adherence Factors against Viral Suppression among Children and Adolescents

	Viral Suppression		Totals	χ2 (p-value)
	Yes	No
Gender
Male	69 (78.4%)	19 (21.6%)	88 (49.4%)	1.642 (0.200)
Female	63 (70%)	27 (30%)	90 (50.6%)
Age
Children 0–9	56 (81.2%)	13 (18.8%)	69 (38.8%)	2.883 (0.090)
Adolescents 10–19	76 (69.7%)	33 (30.3%)	109 (61.2%)
Attending School
No	11 (68.8%)	5 (31.2%)	16 (8.9%)	1.165 (0.280)
Yes	121 (74.7%)	41 (25.3%)	162 (91.1%)
School Type(subset of in school)
Boarding	113 (74.8%)	38 (25.2%)	151 (91.5%)	1.259 (0.533)
Day school	11 (78.6%)	3 (21.4%)	14 (8.5%)
Education Level (subset of in school)
Primary	102 (73.4%)	37 (26.6%)	139 (87.4%)	1.254 (0.263)
Secondary	17 (85.0%)	3 (15.0%)	20 (12.6%)
Clinic Appointments at 3month
Kept clinic appointment	115 (77.7%)	33 (22.3%)	148 (83.1%)	5.760 (0.016)
Missed clinic appointment	17 (56.7%)	13 (43.3%)	30 (16.9%)
Clinic Appointments at 6 month
Kept clinic appointment	100 (76.3%)	31 (23.7%)	131 (76.6%)	1.277 (0.528)
Missed clinic appointment	27 (67.5%)	13 (32.5%)	40 (23.4%)
Clinic Appointments at 12 month
Kept clinic appointment	12 (66.7%)	6 (33.3%)	18 (52.9%)	3.853 (0.278)
Missed clinic appointment	9 (56.2%)	7 (43.8%)	16 (47.1%)
ART Adherence Morisky Good
Yes	126 (75.4%)	41 (24.6%)	167 (93.8%)	16.584 (<0.001)
Not done	6 (54.5%)	5 (45.5%)	11 (6.2%)
Received Booster Adherence
No	13 (36.1%)	23 (63.9%)	36 (20.2%)	60.158 (<0.001)
Yes	119 (83.8%)	23 (16.2%)	142 (79.8%)
Started on Isoniazid Prevention Therapy (IPT)	132 (74.2%)	46 (25.8%)	178 (100%)	-
On Nutritional Support
No	128 (74.4%)	44 (25.6%)	172 (96.6%)	0.182 (0.670)
Yes	4 (66.7%)	2 (33.3%)	6 (3.4%)
HIV Disclosure Done
Yes	111 (72.5%)	42 (27.5%)	153 (85.9%)	1.926 (0.382)
No	21 (84%)	4 (16%)	25 (14.1%)
Antiretroviral Pill Regimen
1st line	101 (73.7%)	36 (26.3%)	137 (77.0%)	0.059 (0.809)
2nd line	31 (75.6%)	10 (24.4%)	41 (23%)
Enhanced Adherence Counseling (EAC)
Yes	39 (88.6%)	5 (11.4%)	44 (89.8%)	144.6 (<0.001)
No	5 (100%)	0 (0%)	5 (10.2%)